Table 1.
Tumor | In the artery phase | In the portal phase | In the late phase |
FNH | Spoked-wheel enhancement | Hyperenhancing/or with scar | Iso/hyperenhancing/or with scar |
Hemangiomas | Peripheral nodular enhancement and centripetal fill-in | Partial/complete centripetal fill-in | Partial/complete centripetal fill-in |
HCC | Hyperenhancing | Iso/hypoenhancement | Hypoenhancing |
Metastatic tumor | Rim-like or variable intralesional enhancement | Homogeneous or heterogeneous hypoenhancement | Hypoenhancement (often marked hypoenhancement) |
Hepatic carcinosarcoma | Peripheral nodular or irregular rim enhancement with large internal non-enhancing area | Peripheral isoenhancing with large internal non-enhancement area | Peripheral hypoenhancing with large internal non-enhancement area |
FNH: Focal nodular hyperplasia; HCC: Hepatocellular carcinoma.